FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,190 | -34.5% | 1,494 | -22.9% | 0.00% | – |
| Q2 2023 | $17,074 | +13.8% | 1,938 | -21.6% | 0.00% | – |
| Q1 2021 | $15,000 | -25.0% | 2,473 | -8.9% | 0.00% | – |
| Q4 2020 | $20,000 | +25.0% | 2,716 | 0.0% | 0.00% | – |
| Q3 2020 | $16,000 | -46.7% | 2,716 | -23.6% | 0.00% | – |
| Q2 2020 | $30,000 | +328.6% | 3,557 | +111.6% | 0.00% | – |
| Q2 2019 | $7,000 | -12.5% | 1,681 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | -27.3% | 1,681 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -21.4% | 1,681 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | -22.2% | 1,681 | 0.0% | 0.00% | – |
| Q2 2018 | $18,000 | – | 1,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |